Testosterone topical Tostrelle - ProStrakan

Drug Profile

Testosterone topical Tostrelle - ProStrakan

Alternative Names: CP 601B; Tostrelle

Latest Information Update: 07 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cellegy Pharmaceuticals
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Female testosterone deficiency

Most Recent Events

  • 23 Jan 2015 Biomarkers information updated
  • 31 Dec 2006 No development reported - Phase-II for Female testosterone deficiency in United Kingdom (Topical)
  • 31 Dec 2006 No development reported - Phase-II for Female testosterone deficiency in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top